New York Senate Bill S07435

New York 2025-2026 Regular Session

• Introduced: 4/16/25
• Refer: 4/16/25

Caption

Authorizes pharmacists to dispense HIV pre-exposure and post-exposure prophylaxis.

Impact

The implementation of S07435 is likely to have significant implications for state laws, particularly within the education law section governing healthcare practices. By allowing pharmacists to dispense these medications, the bill not only expands the role of pharmacists in patient care but also addresses barriers that individuals might face in accessing HIV prevention tools. This change may lead to increased awareness of HIV prevention and facilitate timely intervention, potentially decreasing the number of new infections. It aims at equipping pharmacists with the necessary training and tools to support their patients effectively.

Summary

Bill S07435 is aimed at enhancing healthcare access by authorizing licensed pharmacists to dispense HIV pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP). The bill's provisions enable pharmacists to provide a seven-day starter pack of PEP following potential HIV exposure, and allow for a supply of PrEP to be dispensed for a period ranging from thirty to sixty days. This is intended to improve the accessibility of critical HIV prevention medications to individuals who may be at risk, thus supporting public health initiatives aimed at reducing the rates of HIV infection in New York State.

Contention

While the bill is expected to receive support for its public health benefits, there may be points of contention regarding pharmacist training and oversight, particularly concerning the adequacy of training programs and the assurance that patients are receiving comprehensive care. Concerns could also arise around the possibility of under-regulation in dispensing such critical health interventions, emphasizing the need for proper guidelines and monitoring to ensure patient safety and efficacy of treatment outcomes.